Eliot Forster (F-Star Biotechnology Ltd. (F-Star Therapeutics))

Forster, Eliot (F-Star 201810– CEO before Immunocore + Creabilis + Solace Pharmaceuticals + Pfizer + GSK)

	Organisation	F-Star Biotechnology Ltd. (F-Star Therapeutics)
	Former/major organisation	Immunocore Ltd.
	Group	Immunocore (Group)
	Product	ImmTAC technology

Record changed: 2022-06-27

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

More documents for Eliot Forster

[1] F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London....
[2] Immatics N.V.. (9/15/20). "Press Release: Immatics Appoints Biotech Executive Eliot Forster to Board of Directors". Tübingen & Houston, TX....
[3] Avacta Group plc. (10/18/19). "Press Release: Proposed Placing and Subscription to Raise up to £9 Million and Notice of General Meeting"....
[4] F-Star Biotechnology Ltd.. (5/14/19). "Press Release: F-star Expedites Its Transition to a Wholly-owned Portfolio Strategy". Cambridge....
[5] F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)